your market intelligence analyst
Search Results
34 results
Your search is now limited to «Excipients» expert search.
Takeda Pharmaceutical 05/29/2020 08:00
Osaka, JAPAN, May 29, 2020 – Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on a Type II Variation regulatory application and recommended the approval of a pre-filled syringe presentation of TAKHZYRO® (lanadelumab).
Benzinga 05/28/2020 13:57
Moderna Inc (NASDAQ: ) is progressing rapidly in its program to develop an mRNA vaccine for SARS-CoV-2, codenamed mRNA-1273. What Happened. The Luxembourg-based contract development and manufacturing organization Corden Pharma announced Thursday an amendment to its existing manufacturing agreement with Moderna that will enable it to manufacture large-scale volumes of the latter's lipid excipients to be used in the making of mRNA-1273. The manufacturing will be done by CordenPharma facilities in France and Colorado. The expanded agreement ...
PR Newswire 05/28/2020 07:45
LUXEMBOURG, 28 mai 2020 /PRNewswire/ -- CordenPharma, une organisation de développement et de fabrication sous contrat (façonnier) à service complet pour la fourniture de principes actifs, de médicaments et d'emballages pharmaceutiques, annonce la signature d'un amendement à son accord de...

Personal Care

Household Products

Business Issues


Companies - Public

Companies - Venture Funded

Information Technologies


Job Titles